ClinicalTrials.Veeva

Menu

Wolff-Parkinson-White Syndrome Anterograde Refractory Period of Accessory Duct (WPW)

N

Nantes University Hospital (NUH)

Status

Terminated

Conditions

Wolff-Parkinson-White Syndrome

Treatments

Procedure: esophagal stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT00873470
BRD 08/9-I

Details and patient eligibility

About

The study consists of the realization of a new esophageal stimulation for patients already stimulated 10 years ago.

The investigators would like to make a long term evaluation of the evolution of anterograde effective refractory period of accessory duct in the WPW syndrome.

This study will be realized by esophageal stimulation.

Enrollment

13 patients

Sex

All

Ages

21 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 21 < age < 64 years
  • First esophagal stimulation with evaluation of effective anterograde refractory period > 10 years
  • Informed consent signed
  • Diagnosis of Wolff-Parkinson-White syndrome
  • No procedure of ablation of accessory duct

Exclusion criteria

  • Ablation of accessory duct
  • Patient with contraindication to esophageal stimulation
  • Patient with contraindication to effort test

Trial design

13 participants in 1 patient group

Stimulation
Experimental group
Description:
All patients included have the stimulation
Treatment:
Procedure: esophagal stimulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems